Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

1(20%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_2

20%

Ph phase_1

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

4(80.0%)

Phase 2Efficacy & side effects

1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Detailed Status

Completed4

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 14 (80.0%)

Phase 21 (20.0%)

Trials by Status

completed480%

recruiting120%

Recent Activity

1 active trials

Showing 5 of 5

recruitingphase_2

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

NCT06143956

completedphase_1

Clinical Trials (5)

Showing 5 of 5 trials

NCT06143956Phase 2

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Recruiting

NCT05623839Phase 1

A Study of LY3305677 in Participants With Obesity Or Overweight

Completed

NCT03928379Phase 1

A Study of LY3305677 in Participants With Type 2 Diabetes

Completed

NCT03325387Phase 1

A Study of Multiple Doses of LY3305677 in Healthy Participants

Completed

NCT02972645Phase 1

A Study of LY3305677 in Healthy Participants

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5